Rosa damascena, which belongs to the Rosaceae family, is considered as one of the most important plants used in traditional medicine due to its different pharmacological properties, such as treatment of abdominal and chest pain, menstrual bleeding, and reduction of inflammation. The objective of our study was to investigate the hypoglycemic efficacy of R. damascene.Aqueous and methanolic extracts were prepared from the petals of R. damascena mill (RDM). The phenolic content of the extracts was assessed using the Folin-Ciocalteu colorimetric method. The hypoglycemic activity was evaluated by the determination of in vitro alpha-amylase inhibitory activity. The in vivo post-prandial hypoglycemic effect was performed in normal and alloxan-induced diabetic mice. Acarbose (alpha-glucosidase inhibitor) was used as a standard drug.The total phenolic content of aqueous and methanolic extracts was 29.23 gGAE/l and 58.8 gGAE/l. The alpha-amylase inhibition assay was performed using concentrations of (20, 40, 60, 80, 100, and 120 µg/ml) of aqueous extract, methanolic extract, and acarbose. The percentage inhibition of alpha-amylase was dependent on dose and varied between (33.66-89.96%), (41.57-92.16%) and (23.4-81.82%), respectively. Both aqueous and methanolic extracts revealed higher inhibitory activity of alpha-amylase compared to acarbose.Oral administration of methanolic extract in normal and diabetic mice significantly decreased glucose blood levels after maltose loading in a dose-dependent manner. These results suggest that R. damascena petal extracts might have a hypoglycemic effect. They also imply that R. damascena may have anti-diabetic properties by inhibiting of alphaglucosidase-mediated carbohydrate absorption in the intestine and lowering postprandial glucose levels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.